@windhamvp

A revolutionary blood test that can detect cancer Liquid biopsies: A $20 billion market ready to explode.

Dr. Victor Velculescu envisions a day — not so far off — when screening for cancer will become as simple as a blood test during your annual physical. Unique cancer … Continued

Novocure Files Premarket Approval Supplement Application With FDA for Second Generation Optune System

Second generation Tumor Treating Fields delivery system is more than 50 percent lighter and 50 percent smaller than first generation Optune HELIER, Jersey – Novocure (NASDAQ: NVCR) filed a premarket … Continued

L’Oréal and Lexington firm developing tech that measures ultraviolet exposure to skin

French cosmetics group L’Oréal and Lexington-based MC10 have unveiled a wearable technology that can measure ultraviolet exposure. MC10 has been working with L’Oréal’s Research and Innovation lab in San Francisco … Continued

MC10 Reshapes Research with the Introduction of the BioStamp Research Connect™ System First Product to Leverage the Novel BioStamp® Conformal Sensing Platform; Provides a Complete Hardware and Software Solution for Researchers

LEXINGTON, Mass.–(BUSINESS WIRE)–MC10, Inc. today unveiled the BioStamp Research Connect System (BioStampRC™), providing researchers with an end-to-end solution for seamlessly gathering physiological data. Flexible body-worn sensors enable study subjects to … Continued